On October 10, Jeremy Farrar, director of the Wellcome Trust, delivered the 12th Annual Lecture organised by the Medicines and Healthcare products Regulatory Agency (MHRA) in London. Speaking to an audience of leaders from across the UK life sciences community, Farrar explained how recent political events in Europe and beyond have shaken the foundations of long-established international structures including medicines regulation. A functioning regulation system ensures that medicines are approved safe and effective before being used widely by patients. The MHRA acknowledged the potential risks regarding Brexit. With three rounds of negotiations concluded and little agreed, the reality of a no-deal Brexit looms large over both the European Medicines Agency (EMA) and the MHRA.
展开▼
